UK markets open in 1 hour 10 minutes

The Biotech Growth Trust PLC (BIOG.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
950.00-2.00 (-0.21%)
At close: 04:35PM BST

The Biotech Growth Trust PLC

601 Lexington Avenue
54th Floor
New York, NY 10022
United States
212-739-6400
https://www.biotechgt.com/index.php/biog/home/overview/

Sector(s): Financial Services
Industry: Asset Management
Full-time employees: 

Key executives

NameTitlePayExercisedYear born
Mr. Samuel David IsalyPortfolio ManagerN/AN/A1945
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.

Corporate governance

The Biotech Growth Trust PLC’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.